SWHR’s goal is to ensure increased funding for women’s health research and for funding to parallel increases for federal health agencies to allow them to continue to carry out their important missions. SWHR believes they must be adequately funded to accomplish their goals.
The Women’s Health Office Act (WHOA) in 1994 established offices of women’s health in the Centers for Disease Control and Prevention (CDC), Agency for Healthcare Research and Quality (AHRQ), and the Food and Drug Administration (FDA). Women’s health research appeared a priority for the next ten years, as funding for federal agencies engaged in trials and research grew.
However, since 2003, funding levels for these crucial programs has grown at a significantly slower pace. In 2013, the implementation of sequestration on funding landed a crushing blow to funding for medical research and women’s health, and continues to affect federal budget-making.
SWHR continues to advocate for sufficient levels of federal funding for the National Institutes of Health (NIH), the Food and Drug Administration, Agency for Healthcare Research and Quality, and the Centers for Disease Control and Prevention. Further, SWHR supports the various women’s health related offices in NIH, FDA, CDC, AHRQ, Health Resources and Services Administration, and Substance Abuse and Mental Health Services Administration.
Read more about the devastating effects of sequestration on women’s health research »
Why it matters:
Adequately funding for these offices supports life-changing research investigating sex differences and women’s health. The more resources provided to researchers, the more easily they can incorporate women and minorities into their trials. Investment in research today leads to better and safer medicine in the future.
More from SWHR:
- Click here to read SWHR’s annual appropriation testimony.
Find federal offices of women’s health: